Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma

Joseph M. Connors, Stephen M. Ansell, Michelle Fanale, Steven I. Park, Anas Younes

Research output: Contribution to journal › Letter › peer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma'. Together they form a unique fingerprint.